Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Plasma Cell Neoplasm”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00003938
What this trial is testing

Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients

Who this might be right for
Cancer
European Organisation for Research and Treatment of Cancer - EORTC 115
Not applicableEnded earlyNCT00918658
What this trial is testing

Study of Natural Killer Cells in Bone Marrow and Blood Samples From Patients With and Without Hematologic Cancer

Who this might be right for
LeukemiaMultiple Myeloma and Plasma Cell Neoplasm
Case Comprehensive Cancer Center 34
Large-scale testing (Phase 3)Study completedNCT00037791
What this trial is testing

Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia

Who this might be right for
NeoplasmsThrombocytopeniaMultiple Myeloma+1 more
Pfizer 180
Testing effectiveness (Phase 2)Study completedNCT00004158
What this trial is testing

Radiation Therapy Using Holmium Ho 166 DOTMP Plus Melphalan and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Fred Hutchinson Cancer Center
Not applicableNot Yet RecruitingNCT07482761
What this trial is testing

Multiple Myeloma t(4 ;14) FFPE Samples

Who this might be right for
Multiple Myeloma and Malignant Plasma Cell Neoplasms
BIWAKO 20
Large-scale testing (Phase 3)Study completedNCT00416897
What this trial is testing

Dexamethasone and Chemotherapy With or Without Plasma Exchange in Patients With Newly Diagnosed Multiple Myeloma and Acute Kidney Failure

Who this might be right for
Multiple Myeloma and Plasma Cell NeoplasmRenal Failure
University of Glasgow 280
Early research (Phase 1)Ended earlyNCT00369291
What this trial is testing

CpG 7909 in Treating Patients Who Have Undergone Autologous Stem Cell Transplant

Who this might be right for
Germ Cell TumorLeukemiaLymphoma+1 more
Masonic Cancer Center, University of Minnesota 19
Early research (Phase 1)Study completedNCT00003962
What this trial is testing

Interleukin-2 Following Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Not applicableWithdrawnNCT00499668
What this trial is testing

Aprepitant or Ondansetron in Treating Nausea and Vomiting Caused By Opioids in Patients With Cancer

Who this might be right for
Myeloproliferative DisordersLeukemiaLymphoma+5 more
Vanderbilt-Ingram Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT00281879
What this trial is testing

Donor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
OHSU Knight Cancer Institute 200
Early research (Phase 1)Looking for participantsNCT07239323
What this trial is testing

In VIVO CAR-T Therapy for Relapsed/Refractory Hematological Malignancies

Who this might be right for
B-Acute Lymphoblastic LeukemiaB Cell Non-Hodgkin's LymphomaMultiple Myeloma
Chongqing Precision Biotech Co., Ltd 24
Testing effectiveness (Phase 2)Ended earlyNCT00637767
What this trial is testing

High-Dose Melphalan With or Without Radiolabeled Monoclonal Antibody in Treating Patients With Multiple Myeloma Undergoing an Autologous Stem Cell Transplant

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
University of Southampton 25
Not applicableStudy completedNCT00521430
What this trial is testing

Donor Stem Cell Transplant After Conditioning Therapy in Treating Patients With Hematologic Cancer, Recurrent or Metastatic Solid Tumor, or Other Disease

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+3 more
Asan Medical Center 30
Testing effectiveness (Phase 2)Study completedNCT00028600
What this trial is testing

Peripheral Stem Cell Transplant in Treating Patients With Multiple Myeloma

Who this might be right for
Multiple MyelomaPlasma Cell Neoplasm
Alliance for Clinical Trials in Oncology 60
Testing effectiveness (Phase 2)Study completedNCT00005797
What this trial is testing

Bone Marrow Transplant in Treating Patients With Hematologic Cancers

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaMultiple Myeloma and Malignant Plasma Cell Neoplasms+2 more
H. Lee Moffitt Cancer Center and Research Institute 125
Testing effectiveness (Phase 2)Study completedNCT00012350
What this trial is testing

Phase II Evaluation of FTase Inhibitor (FTI)in Treatment of Advanced Multiple Myeloma

Who this might be right for
Multiple Myeloma
H. Lee Moffitt Cancer Center and Research Institute 44
Early research (Phase 1)Study completedNCT03762291
What this trial is testing

Multiple Myeloma Trial of Orally Administered Salmonella Based Survivin Vaccine

Who this might be right for
Multiple Myeloma
Baylor College of Medicine 1
Early research (Phase 1)Ended earlyNCT00687674
What this trial is testing

Sorafenib, Lenalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Mayo Clinic 13
Testing effectiveness (Phase 2)Study completedNCT00003195
What this trial is testing

Total-Body Irradiation, Busulfan, and Interferon Alfa Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00003874
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Leukemia

Who this might be right for
LeukemiaLymphoma
Fred Hutchinson Cancer Center
Next Page